Skip to main content
Signal8

CYANOTECH CORP (CYAN)

Established in 1983 and headquartered in Kailua-Kona, Hawaii, Cyanotech Corporation specializes in the global cultivation, processing, and distribution of natural products derived from microalgae. Its key product offerings include BioAstin Hawaiian Astaxanthin, a powerful dietary antioxidant acclaimed for promoting skin health and supporting eye, joint, and immune system functions; it is utilized as both a dietary supplement and an ingredient. Another significant product is Hawaiian Spirulina Pacifica, a highly nutritious dietary supplement formulated to enhance energy levels, bolster the immune system, provide cardiovascular benefits, and deliver a rich source of antioxidant carotenoids. Beyond its product lines, Cyanotech also offers contract extraction services. The company reaches its customers through a diverse array of sales channels, encompassing third-party distributors, retailers, and online platforms, as well as direct sales to consumers. Additionally, it supplies products in bulk to manufacturers, formulators, and distributors within the health foods, nutraceuticals, and dietary supplement industries.

Sector: Medicinal Chemicals & Botanical Products

Industry: Packaged Foods

Cyanotech Corporation logo

Cyanotech Corporation

OTC:CYANConsumer Defensive
+0.00%$0.6271
Mkt Cap$4.57M
Float4.85M
O/S7.29M
Inst Own-
SI<0.1%
Dilution
FormDescription
15-12G
SEC Filing
13E3/A
AMENDMENT NO. 2
13E3/A
AMENDMENT NO. 1
13E3
SCHEDULE 13E-3
10-Q
Quarterly Report
4
JENNIFER MIYASHIRO ISO
3
JENNIFER MIYASHIRO CFO
4
FORM 4 DM
4
FORM 4 DV
4
FORM 4 MD
8-K
1.01,2.03,9.01
8-K
5.02,5.07,8.01
10-Q
Quarterly Report
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
ARS
SEC Filing
DEF 14A
Definitive Proxy Statement
10-K
Annual Report
4
FORM 4 MC
4
FORM 4 JB
4
FORM 4 AN
4
FORM 4 GJ

1-25 of 870

…